|
2022 Conference Publication Antiarrhythmic Effects of Phenytoin, a Novel Heart Failure Diastolic Ryanodine Channel Inhibitor, in Human Failing VentricleSpratt, M., Dashwood, A., Cheesman, E., Haqqani, H., Wong, Y., Chan, W., Laver, D. and Molenaar, P. (2022). Antiarrhythmic Effects of Phenytoin, a Novel Heart Failure Diastolic Ryanodine Channel Inhibitor, in Human Failing Ventricle. 70th Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand, Gold Coast, QLD Australia, 11-14 August 2022. Chatswood, NSW Australia: Elsevier. doi: 10.1016/j.hlc.2022.06.062 |
|
2022 Conference Publication Post-transplant cardiac contractility and mitochondrial function is preserved following 8 hours hypothermic ex vivo perfusion in sheepSee Hoe, L., Bouquet, M., Hyslop, K., Passmore, M., Wells, M., Sato, K., Wilson, E., Wildi, K., Skeggs, K., Palmeri, C., Reid, J., O'Neill, H., Bartnikowski, N., Jung, J., Ainola, C., Abbate, G., Colombo, S., Obonyo, N., McDonald, C., Shuker, T., Heinsar, S., Haymet, A., Engkilde-Pedersen, S., Peart, J., Molenaar, P., Li Bassi, G., Suen, J., McGiffin, D. and Fraser, J. (2022). Post-transplant cardiac contractility and mitochondrial function is preserved following 8 hours hypothermic ex vivo perfusion in sheep. 70th Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand, Gold Coast, QLD, Australia, 11-14 August 2022. Chatswood, NSW, Australia: Elsevier. doi: 10.1016/j.hlc.2022.06.547 |
|
2018 Conference Publication Development of an ovine model of heart transplantation following 24-hour brain stem deathSee Hoe, L., Engkilde-Pedersen, S., Obonyo, N., Wells, M., Boon, C., Bartnikowski, N., Passmore, M., McDonald, C., Black, D., Molenaar, P., Diab, S., Suen, J., Marasco, S., McGiffin, D. and Fraser, J. (2018). Development of an ovine model of heart transplantation following 24-hour brain stem death. 66th Cardiac Society of Australia and New Zealand Annual Scientific Meeting, the International Society for Heart Research Australasian Section Annual Scientific Meeting and the 12th Annual Australia and New Zealand Endovascular Therapies Meeting, Brisbane, Australia, 2-5 August 2018. Chatswood, NSW, Australia: Elsevier . doi: 10.1016/j.hlc.2018.06.111 |
|
2015 Conference Publication Transcriptional Regulation of Taste Receptor Genes: Novel Insights From In Silico and Cardiac Gene Expression AnalysesFoster, Simon R., Porrello, Enzo R., Stefani, Maurizio, Smith, Nicola J., Molenaar, Peter, dos Remedios, Cris G., Thomas, Walter G. and Ramialison, Mirana (2015). Transcriptional Regulation of Taste Receptor Genes: Novel Insights From In Silico and Cardiac Gene Expression Analyses. 15th Scientific Meeting of the Australasian Association for ChemoSensory Science (AACSS), Brisbane, QLD Australia, 03-05 December 2014. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/chemse/bjv008 |
|
2013 Conference Publication The role of beta1 adrenoceptors in the development of alcohol dependenceKlenowski, P. M., Holgate, J., Bellingham, M., Molenaar, P. and Bartlett, S. (2013). The role of beta1 adrenoceptors in the development of alcohol dependence. Neuroscience 2013: 43rd Annual Meeting of the Society for Neuroscience, San Diego, CA, USA, 9-13 November, 2013. |
|
2006 Conference Publication Human heart beta1-adrenoceptor heterogeneity - diversification through 'affinity states' and polymorphismMolenaar, P., Chen, L., Semmler, A. B., Parsonage, W. A. and Kaumann, A. (2006). Human heart beta1-adrenoceptor heterogeneity - diversification through 'affinity states' and polymorphism. 15th World Congress of Pharmacology, Beijing, China, 7 - 9 July, 2006. China: Institute of Vascular Medicine. |
|
2006 Conference Publication Carvedilol causes a greater increase in heart function in idiopathic dilated cardiomyopathy patients with ARG389-compared to GLY389 Beta1-adrenoceptorsMolenaar, P., Chen, Lu, Meyers, E., Javorsky, G., Burstow, M., Lucas, P., Lolekha, J., Atherton, A., Semmler, A. B., Savarimuthu, S., Fong, K. M., Yang, I. A., Galbraith, A. and Parsonage, W. A. (2006). Carvedilol causes a greater increase in heart function in idiopathic dilated cardiomyopathy patients with ARG389-compared to GLY389 Beta1-adrenoceptors. The Australian Health and Medical Research Congress, Melbourn, Australia, 26th November - 1st December, 2006. Australia: Australian Govenment NHMRC. |
|
2006 Conference Publication Contractile responses through Gs-coupled receptors are reduced by phosphodiesterase3 activity in human isolated myocardiumChrist, T., Molenaar, P., Galindo-Tovar, A., Ravens, U. and Kaumann, A. J. (2006). Contractile responses through Gs-coupled receptors are reduced by phosphodiesterase3 activity in human isolated myocardium. Compartmentalization of cyclic AMP signalling, Cambridge, U.K., 29-30 March, 2006. |
|
2006 Conference Publication Beta1-adrenoceptor (AR) Arg389Gly polymorphisms affect responses to carvedilol in patients with idiopathic dilated cardiomyopathyChen, L., Meyers, D., Semmler, A.B., Yang, I., Pakorn, L., Lucas, M., Jovarsky, G., Savarimuthu, S., Galbraith, A., Parsonage, W. and Molenaar, P. (2006). Beta1-adrenoceptor (AR) Arg389Gly polymorphisms affect responses to carvedilol in patients with idiopathic dilated cardiomyopathy. 15th World Congress of Pharmacology, Beijing, China, 2nd - 7th July, 2006. China: Chinese Pharmacological Society. |
|
2006 Conference Publication Human heart Beta-adrenoceptors:-Beta1-adrenoceptor diversification through 'affinity states' and polymorphismMolenaar, P., Chen, Lu, Semmler, A. B., Parsonage, W. A. and Kaumann, A. (2006). Human heart Beta-adrenoceptors:-Beta1-adrenoceptor diversification through 'affinity states' and polymorphism. The Australian Health & Medical Research Congress, Melbourne, Australia, 26 November - 1 December, 2006. Australia: Australian Govenment NHMRC. |
|
2005 Conference Publication Carvedilol blocks beta2- more than beta1-adrenoceptors in human heartMolenaar, P., Christ, T., Ravens, U., Chen, L. and Kaumann, A. (2005). Carvedilol blocks beta2- more than beta1-adrenoceptors in human heart. Joint Meeting of ASCEPT & APSA, Melbourne, Australia, 4 - 7 Dec, 2005. Australia: ASCEPT. |
|
2005 Conference Publication Carvedilol causes greater persistent blockage of beta2- than beta1-adrenoceptors in human failing myocardiumKaumann, A. J., Christ, T., Ravens, U. and Molenaar, P. (2005). Carvedilol causes greater persistent blockage of beta2- than beta1-adrenoceptors in human failing myocardium. BPS Summer Meeting 2005, Cambridge, U.K., July, 2005. |
|
2005 Conference Publication Rationale for treatment of heart failure by blockade of ventricular serotonin receptors appearing in heart failureQvigstad, E., Brattelid, T., Sjaastad, I., Molenaar, P., Birkeland, J. A., Andressen, K. W., Krobert, K. A., Sejersted, O. M., Skomedal, T., Osnes, J-B., Kaumann, A. J. and Levy, F. O. (2005). Rationale for treatment of heart failure by blockade of ventricular serotonin receptors appearing in heart failure. International Soc for Heart Research, European Section Mtg, Norway, 21-25 Jun, 2005. Italy: Medimond International. |
|
2005 Conference Publication Carvedilol blocks beta2-adrenoceptors more than beta1-adrenoceptors in human atriumKaumann, A. J. and Molenaar, P. (2005). Carvedilol blocks beta2-adrenoceptors more than beta1-adrenoceptors in human atrium. BPS Summer Meeting 2005, Cambridge, U.K., July, 2005. |
|
2004 Conference Publication Investigation of urotensin-II converting enzyme activity in human cells and bloodKearns, P., Russell, F. D., Toth, I. and Molenaar, P. (2004). Investigation of urotensin-II converting enzyme activity in human cells and blood. 8th Annual Scientific Sessions of the Latin American Section of the International-Society for Heart Research, Brisbane, Qld, Australia, 7th - 11th August, 2004. United Kingdom: Academic Press. doi: 10.1016/j.yjmcc.2004.05.003 |
|
2004 Conference Publication Regulatory myosin light chain signaling pathways in urotensin-II-mediated positive inotropic effect in human right atriumRussell, F. D. and Molenaar, P. (2004). Regulatory myosin light chain signaling pathways in urotensin-II-mediated positive inotropic effect in human right atrium. 2004 ISHR World Congress Meeting, Brisbane, Qld, Australia, 7 - 11 August, 2004. London, England: Academic Press. doi: 10.1016/j.yjmcc.2004.05.003 |
|
2004 Conference Publication Activation of calcineurin in human failing heart ventricle by endothelin-1, angiotensin II and urotensinLi, J., Wang, J., Russell, F. D. and Molenaar, P. (2004). Activation of calcineurin in human failing heart ventricle by endothelin-1, angiotensin II and urotensin. 2004 ISHR World Congress Meeting, Brisbane, Qld, Australia, 7-11 Aug, 2004. United Kingdom: Academic Press. |
|
2004 Conference Publication Both 1- and 2-adrenoceptors mediate increases in contractile force and hastening of relaxation in human atriumKrause, E.-G., Bartel, S., Vetter, D., Karczewski, P., Russell, F. D., Kaumann, A. J. and Molenaar, P. (2004). Both 1- and 2-adrenoceptors mediate increases in contractile force and hastening of relaxation in human atrium. 2004 ISHR World Congress Meeting, Brisbane, Qld, Australia, 7 - 11 August, 2004. United Kingdom: Academic Press. doi: 10.1016/j.yjmcc.2004.05.003 |
|
2003 Conference Publication Regulatory myosin light chain signaling pathways in urotensin-II-mediated positive inotropic effect in human right atriumRussell, F. D. and Molenaar, P. (2003). Regulatory myosin light chain signaling pathways in urotensin-II-mediated positive inotropic effect in human right atrium. ASCEPT, Sydney, 30 Nov - 3 Dec, 2003. Australia: Australasian Society of Clinical & Experimental Pharmacologists & Toxicologists. |
|
2003 Conference Publication Intrinsic sympathomimetic activity (ISA) of (-)-pindolol mediated through a (-)-propranolol-resistant site of the beta1-adrenoceptor in human right atriumMolenaar, P. and Kaumann, A. J. (2003). Intrinsic sympathomimetic activity (ISA) of (-)-pindolol mediated through a (-)-propranolol-resistant site of the beta1-adrenoceptor in human right atrium. ASCEPT, Sydney, 30 Nov - 3 Dec, 2003. Australia: Australasian Society of Clinical & Experimental Pharmacologists & Toxicologists. |
